data, research that focuses on better understanding of placental and breast physiology, as well as drug and antibody transport, may help inform decision-making. With the development of this guideline, the ACR recognizes the key role of clinical rheumatologists not only in managing disease activity but also in understanding the interactions of RMDs and their therapies in the context of reproductive health. The most important goal of this guideline is to provide substance and direction for